Lamivudine And Zidovudine Tablet, Film Coated
Product Images NDC 31722-739

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 31722-739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber1

FDA Label Image

Lami

Chemical structure of the active ingredient Lamivudine, showing the molecular arrangement of atoms including hydroxyl, amino, and sulfur groups in a bicyclic framework.*

FDA Label Image

Lamivudine And Zidovudine Tablets 60s Count Label

Lamivudine and Zidovudine Tablets USP 150 mg/300 mg film-coated tablets label by Camber Pharmaceuticals, Inc. The label states the package contains 60 tablets for oral use, includes dosage storage instructions (20° to 25°C), and cautions against use if the safety seal is broken. Manufactured by Hetero Labs Limited, India, for Camber Pharmaceuticals, Inc., Piscataway, NJ.*

FDA Label Image

Zidostructure

Chemical structure of Lamivudine, pictured as part of the Lamivudine and Zidovudine combination drug. The diagram shows the molecular connectivity typical of the nucleoside analog compound used in this human prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.